Dong-A ST Co., Ltd.
KSC: 170900.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jae-Hun Jung
- Employees
- 1,687
- Headquarters
- Seoul, South Korea
- IPO year
- 2013
- Market cap
- ₩415.9B
- Website
- https://www.donga-st.com
Loading 170900…
Loading profile data…Frequently asked questions about 170900
What does Dong-A ST Co., Ltd. (170900.KS) do?
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chr...
Where does 170900.KS trade?
Dong-A ST Co., Ltd. (170900.KS) trades on the Korea Exchange.
What sector is 170900.KS in?
Dong-A ST Co., Ltd. (170900.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Dong-A ST Co., Ltd.?
Jae-Hun Jung is the chief executive officer of Dong-A ST Co., Ltd. (170900.KS).
Where is Dong-A ST Co., Ltd. headquartered?
Dong-A ST Co., Ltd. is headquartered in South Korea.
Does 170900.KS pay a dividend?
Yes — Dong-A ST Co., Ltd. (170900.KS) paid a trailing twelve-month dividend of KRW 700.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 170900.KS go public?
Dong-A ST Co., Ltd. (170900.KS) completed its initial public offering in 2013.